跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 22,377 条关于
“inflammatory conditions”
全部
22,377
临床试验
11,301
药物
440
机构
70
资讯
10,566
去年
FDA Approves Celltrion's Avtozma, a Tocilizumab Biosimilar, for Multiple Inflammatory Conditions
去年
MoonLake Immunotherapeutics Advances Sonelokimab Through Phase 3 Trials for Multiple Inflammatory Conditions
去年
China Medical System's MG-K10 Advances in Phase III Trials for Multiple Inflammatory Conditions
去年
Bimzelx's Novel Dual IL-17 Inhibition Mechanism Drives Five FDA Approvals Across Inflammatory Conditions
9个月前
Sanofi and Regeneron Launch Real-World Studies to Strengthen Dupilumab's Evidence Base Across Multiple Inflammatory Conditions
去年
FDA Clears IND for Nurix and Gilead's Novel IRAK4 Degrader GS-6791/NX-0479 for Inflammatory Conditions
去年
FDA Approves Otulfi, a Stelara Biosimilar, for Inflammatory Conditions
2年前
EMA Approves First Ustekinumab Biosimilar, Uzpruvo, for Inflammatory Conditions
2年前
FDA Approves Pyzchiva (ustekinumab-ttwe), Biosimilar to Stelara, for Inflammatory Conditions
去年
FDA Approves Accord BioPharma's IMULDOSA, a Biosimilar to Stelara, for Inflammatory Conditions
第 1 页,共 1057 页
上一页
下一页